Studies: Taxol-BEP vs. BEP for patients with intermediate prognosisID TrialEORTC 30983Clinicaltrials.gov identifierNCT00003643DescriptionTaxol-BEP vs. BEP for patients with intermediate prognosis StatusclosedStages
Treatment armsNo dataTrial characteristicsNo dataDisease characteristicsNo dataTreatment characteristicsNo dataPatient characteristicsAge between 16 and 50 years
Sex male
ECOG ≤ 2
HematologyThrombocytes ≥ 100.000/µl
Liver functonBilirubin bis 1,25x normal
Transaminasen bis 2x normal
SponsorEuropean Organization for Research and Treatment of CancerAvenue Mounierlaan, 83/11 1200 Brüssel Belgien Coordinating investigator
Principal investigatorNo data |
|